Purdue Pharma dissolved in opioid crisis settlement
US judge approves Purdue Pharma bankruptcy, dissolving OxyContin maker. Sacklers pay $6.5-7B settlement. Learn about Nigeria's opioid awareness.
Category : Search result: pharmaceutical ethics
Corps Member's 'Knacking' Comment Sparks Outrage
A male NYSC member faces investigation after making inappropriate comments about female students. Facebook users petition for action amid growing concerns about student safety.
Pfizer buys Metsera in $10bn weight loss drug deal
Pfizer completes Metsera acquisition worth up to $10 billion, entering the competitive weight loss drug market. Learn how this deal positions Pfizer against Novo Nordisk.
Nigeria gets €6.3M EU-UNICEF health production deal
Federal Government partners with European Union and UNICEF in groundbreaking €6.3 million initiative to boost local manufacturing of essential health commodities and reduce import dependency.
Nigeria signs €6.3M health production deal with EU-UNICEF
Federal Government signs landmark agreement to strengthen local manufacturing of essential health commodities, reducing import dependency and creating jobs.
AstraZeneca Profit Soars with 19% Revenue Growth
British-Swedish pharmaceutical giant AstraZeneca reports massive profit jump with 19% revenue growth. Discover how emerging markets and cancer drugs drove this impressive performance.
Neimeth Pharmaceuticals Profit Soars 120%
Neimeth International Pharmaceuticals records massive 120% operating profit growth as strategic marketing expansion and cost management deliver outstanding results in Nigerian healthcare sector.
Professionalism Key to Nigeria's Business Growth - Leaders
Top Nigerian business leaders emphasize that embracing professional standards and ethical practices is the key driver for sustainable economic growth and global competitiveness in today's challenging market environment.
NAFDAC Boss Praised for Health Sector Transformation
NAFDAC's Director-General Prof. Moji Adeyeye earns commendation for transformational leadership that's reshaping Nigeria's healthcare landscape and regulatory standards.
Edo State to Begin Local Drug Production in 2026
Edo State announces groundbreaking pharmaceutical manufacturing initiative to produce essential medicines locally by 2026, reducing import dependency and creating thousands of jobs.
Pfizer Profits Dip as COVID Vaccine Sales Decline
Global pharmaceutical giant Pfizer experiences significant profit decline amid falling COVID-19 product sales. Analysis of impact on Nigerian healthcare market and future outlook.
EU, France invest €10.2M in Nigeria pharma sector
Massive €10.2 million investment aims to boost local drug manufacturing, reduce import dependency, and create thousands of jobs in Nigeria's healthcare sector.
EU & France Invest €10.2M in Nigeria Pharma Industry
Breaking: European Union and France launch massive €10.2 million investment to transform Nigeria's local drug manufacturing capacity and healthcare security.
Profit Over Nigerians: Feyi Fawehinmi's Business Truths
Discover the eye-opening revelations from financial analyst Feyi Fawehinmi about how Nigerian businesses prioritize profits over citizens' welfare and what entrepreneurs can learn from this troubling trend.
ACPN Fights Illegal Drug Distribution in Nigerian Hospitals
ACPN demands immediate government action against unlicensed drug distribution in healthcare facilities, warning of dire consequences for patient safety and public health.
DELSU student rusticated for TikTok video of dying colleague
DELSU student expelled for filming and sharing disturbing video of fellow student's final moments at university health centre on TikTok platform
Tinubu Boosts Local Medicine Manufacturing in Nigeria
President Tinubu's administration takes decisive action to revolutionize Nigeria's pharmaceutical sector with new policies aimed at boosting local medicine manufacturing and reducing import dependency.
Novo Nordisk vs Pfizer: Bidding War for Obesity Drugmaker
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.
GSK boosts 2025 forecast amid Nigeria tariff reforms
British drugmaker GSK raises 2025 profit guidance as Nigeria's tariff reforms create favorable market conditions. Discover how this impacts healthcare costs and medicine availability.
Page 2 of 2